Use of corticosteroids in acute respiratory distress syndrome: Perspective from an indian intensive care unit

Naveen G.S. Chandra, Saraschandra Vallabhajosyula, Barkur A. Shastry, Shashaank Vallabhajosyula, Saarwaani Vallabhajosyula, Kavita Saravu

Research output: Contribution to journalArticle

Abstract

Background: Acute respiratory distress syndrome (ARDS) causes overwhelming inflam- mation, which serves as a potential target for corticosteroids. Despite extensive Western literature, there are no Indian studies evaluating steroids in ARDS. Methods: This was a retrospective study at an Indian intensive care unit (ICU) on ARDS patients. Demographic, clinical, laboratory, and imaging parameters were collected. Patients were divided into cohorts based on steroid use, and some received high-dose (2 mg/kg/day), whereas others received low-dose (1 mg/kg/day) ster- oids. Primary outcomes were in-hospital mortality and secondary outcomes included need for and duration of invasive mechanical ventilation (IMV), IMV-free days, ICU length of stay (LOS), and total LOS. Two-tailed p < 0.05 was considered statistically significant. Results: During the 20-month period, 95 patients [median age 37 (30–47) years; 48 (50.5%) males] met our inclusion criteria. Steroid use was noted in 48 (50.5%) patients [11 (22.9%) low-dose and 37 (77.1%) high-dose]. Baseline characteristics of the cohorts, including ARDS severity indices, were comparable. Of these 95 patients, 70 (73.7%) had sepsis, but microbiological diagnosis was positive only in 17 (17.9%) patients. Steroid use did not significantly influence mortality [odds ratio (OR) 0.6 (0.3–1.4)] or need for IMV [OR 1.0 (0.4–2.6)]. There were no differences in outcomes of IMV-free days, ICU LOS, or total LOS. These outcomes were comparable between the high-dose and low-dose steroid users.

Original languageEnglish
Pages (from-to)118-122
Number of pages5
JournalMedical Journal Armed Forces India
Volume73
Issue number2
DOIs
Publication statusPublished - 01-04-2017

Fingerprint

Adult Respiratory Distress Syndrome
Intensive Care Units
Adrenal Cortex Hormones
Steroids
Artificial Respiration
Length of Stay
Odds Ratio
Hospital Mortality
Sepsis
Retrospective Studies
Demography
Inflammation
Mortality

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Chandra, Naveen G.S. ; Vallabhajosyula, Saraschandra ; Shastry, Barkur A. ; Vallabhajosyula, Shashaank ; Vallabhajosyula, Saarwaani ; Saravu, Kavita. / Use of corticosteroids in acute respiratory distress syndrome : Perspective from an indian intensive care unit. In: Medical Journal Armed Forces India. 2017 ; Vol. 73, No. 2. pp. 118-122.
@article{2d135d3233034d88a1f11ae5a2692258,
title = "Use of corticosteroids in acute respiratory distress syndrome: Perspective from an indian intensive care unit",
abstract = "Background: Acute respiratory distress syndrome (ARDS) causes overwhelming inflam- mation, which serves as a potential target for corticosteroids. Despite extensive Western literature, there are no Indian studies evaluating steroids in ARDS. Methods: This was a retrospective study at an Indian intensive care unit (ICU) on ARDS patients. Demographic, clinical, laboratory, and imaging parameters were collected. Patients were divided into cohorts based on steroid use, and some received high-dose (2 mg/kg/day), whereas others received low-dose (1 mg/kg/day) ster- oids. Primary outcomes were in-hospital mortality and secondary outcomes included need for and duration of invasive mechanical ventilation (IMV), IMV-free days, ICU length of stay (LOS), and total LOS. Two-tailed p < 0.05 was considered statistically significant. Results: During the 20-month period, 95 patients [median age 37 (30–47) years; 48 (50.5{\%}) males] met our inclusion criteria. Steroid use was noted in 48 (50.5{\%}) patients [11 (22.9{\%}) low-dose and 37 (77.1{\%}) high-dose]. Baseline characteristics of the cohorts, including ARDS severity indices, were comparable. Of these 95 patients, 70 (73.7{\%}) had sepsis, but microbiological diagnosis was positive only in 17 (17.9{\%}) patients. Steroid use did not significantly influence mortality [odds ratio (OR) 0.6 (0.3–1.4)] or need for IMV [OR 1.0 (0.4–2.6)]. There were no differences in outcomes of IMV-free days, ICU LOS, or total LOS. These outcomes were comparable between the high-dose and low-dose steroid users.",
author = "Chandra, {Naveen G.S.} and Saraschandra Vallabhajosyula and Shastry, {Barkur A.} and Shashaank Vallabhajosyula and Saarwaani Vallabhajosyula and Kavita Saravu",
year = "2017",
month = "4",
day = "1",
doi = "10.1016/j.mjafi.2016.10.012",
language = "English",
volume = "73",
pages = "118--122",
journal = "Medical Journal Armed Forces India",
issn = "0377-1237",
publisher = "Medical Journal Armed Forces India",
number = "2",

}

Use of corticosteroids in acute respiratory distress syndrome : Perspective from an indian intensive care unit. / Chandra, Naveen G.S.; Vallabhajosyula, Saraschandra; Shastry, Barkur A.; Vallabhajosyula, Shashaank; Vallabhajosyula, Saarwaani; Saravu, Kavita.

In: Medical Journal Armed Forces India, Vol. 73, No. 2, 01.04.2017, p. 118-122.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Use of corticosteroids in acute respiratory distress syndrome

T2 - Perspective from an indian intensive care unit

AU - Chandra, Naveen G.S.

AU - Vallabhajosyula, Saraschandra

AU - Shastry, Barkur A.

AU - Vallabhajosyula, Shashaank

AU - Vallabhajosyula, Saarwaani

AU - Saravu, Kavita

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Background: Acute respiratory distress syndrome (ARDS) causes overwhelming inflam- mation, which serves as a potential target for corticosteroids. Despite extensive Western literature, there are no Indian studies evaluating steroids in ARDS. Methods: This was a retrospective study at an Indian intensive care unit (ICU) on ARDS patients. Demographic, clinical, laboratory, and imaging parameters were collected. Patients were divided into cohorts based on steroid use, and some received high-dose (2 mg/kg/day), whereas others received low-dose (1 mg/kg/day) ster- oids. Primary outcomes were in-hospital mortality and secondary outcomes included need for and duration of invasive mechanical ventilation (IMV), IMV-free days, ICU length of stay (LOS), and total LOS. Two-tailed p < 0.05 was considered statistically significant. Results: During the 20-month period, 95 patients [median age 37 (30–47) years; 48 (50.5%) males] met our inclusion criteria. Steroid use was noted in 48 (50.5%) patients [11 (22.9%) low-dose and 37 (77.1%) high-dose]. Baseline characteristics of the cohorts, including ARDS severity indices, were comparable. Of these 95 patients, 70 (73.7%) had sepsis, but microbiological diagnosis was positive only in 17 (17.9%) patients. Steroid use did not significantly influence mortality [odds ratio (OR) 0.6 (0.3–1.4)] or need for IMV [OR 1.0 (0.4–2.6)]. There were no differences in outcomes of IMV-free days, ICU LOS, or total LOS. These outcomes were comparable between the high-dose and low-dose steroid users.

AB - Background: Acute respiratory distress syndrome (ARDS) causes overwhelming inflam- mation, which serves as a potential target for corticosteroids. Despite extensive Western literature, there are no Indian studies evaluating steroids in ARDS. Methods: This was a retrospective study at an Indian intensive care unit (ICU) on ARDS patients. Demographic, clinical, laboratory, and imaging parameters were collected. Patients were divided into cohorts based on steroid use, and some received high-dose (2 mg/kg/day), whereas others received low-dose (1 mg/kg/day) ster- oids. Primary outcomes were in-hospital mortality and secondary outcomes included need for and duration of invasive mechanical ventilation (IMV), IMV-free days, ICU length of stay (LOS), and total LOS. Two-tailed p < 0.05 was considered statistically significant. Results: During the 20-month period, 95 patients [median age 37 (30–47) years; 48 (50.5%) males] met our inclusion criteria. Steroid use was noted in 48 (50.5%) patients [11 (22.9%) low-dose and 37 (77.1%) high-dose]. Baseline characteristics of the cohorts, including ARDS severity indices, were comparable. Of these 95 patients, 70 (73.7%) had sepsis, but microbiological diagnosis was positive only in 17 (17.9%) patients. Steroid use did not significantly influence mortality [odds ratio (OR) 0.6 (0.3–1.4)] or need for IMV [OR 1.0 (0.4–2.6)]. There were no differences in outcomes of IMV-free days, ICU LOS, or total LOS. These outcomes were comparable between the high-dose and low-dose steroid users.

UR - http://www.scopus.com/inward/record.url?scp=85018706929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018706929&partnerID=8YFLogxK

U2 - 10.1016/j.mjafi.2016.10.012

DO - 10.1016/j.mjafi.2016.10.012

M3 - Article

AN - SCOPUS:85018706929

VL - 73

SP - 118

EP - 122

JO - Medical Journal Armed Forces India

JF - Medical Journal Armed Forces India

SN - 0377-1237

IS - 2

ER -